Skip to content
by Legal Desire
18 April 2023

Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck

Advising firms

Deal team

21 lawyers named
LawyerFirmSeniorityPracticeOffice
Daniel Rees Lead Latham & Watkins LLP Partner corporate Orange County
Matthew Bush Latham & Watkins LLP Partner corporate San Diego
Cheston Larson Latham & Watkins LLP Partner corporate San Diego
Brian Umanoff Latham & Watkins LLP Associate corporate Not stated
Abby Timmons Latham & Watkins LLP Associate corporate Not stated
Jack McKay Latham & Watkins LLP Associate corporate Not stated
Jack Vanderford Latham & Watkins LLP Associate corporate Not stated
Holly Bauer Latham & Watkins LLP Partner benefits and compensation San Diego
Laura Szarmach Latham & Watkins LLP Counsel benefits and compensation Washington, D.C.
Julie Voorhes Latham & Watkins LLP Associate benefits and compensation Not stated
Ben Haas Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Josh Holian Latham & Watkins LLP Partner antitrust Bay Area
Kevin Wu Latham & Watkins LLP Associate antitrust Not stated
Chris Hazuka Latham & Watkins LLP Partner intellectual property Bay Area
Robert Yeh Latham & Watkins LLP Associate intellectual property Not stated
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Samuel Weiner Latham & Watkins LLP Partner tax Century City
Seung (Sam) Yang Latham & Watkins LLP Associate tax Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Bay Area

Stated terms

Stated value
USD 10.8bn (US$10.8 billion)
What the figure measures
Total transaction value
Client
Prometheus Biosciences, Inc.Sell-side
Counterparties
Merck (Buy-side)